Open AccessTreatment Outcomes of Recommended First-Line Antiretroviral Regimens in Resource-Limited Clinics
Author(s) -
Anthony Amoroso,
Martine Etienne-Mesubi,
Anthony Edozien,
Sylvia Ojoo,
Robert Sheneberger,
Michael Obiefune,
Mian Bazle Hossain,
Kristen A. Stafford,
Robert Redfield
Publication year - 2012
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31824e5256
Subject(s) - efavirenz , emtricitabine , medicine , lamivudine , viral load , nevirapine , proportional hazards model , hazard ratio , human immunodeficiency virus (hiv) , confidence interval , immunology , antiretroviral therapy , hepatitis b virus , virus
Although used globally, little data exist on the efficacy of nevirapine (NVP) used in combination with tenofovir (TDF)/emtricitabine or lamivudine (XTC), and no large randomized prospective control trials exists comparing this combination with efavirenz (EFV)/TDF/(XTC).